| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/26/2012 | WO2011127412A3 Soluble human st-2 antibodies and assays |
| 01/26/2012 | WO2011113043A3 Sample storage for molecular and immunological detection |
| 01/26/2012 | WO2011109726A3 Homologous multi-specific antibodies |
| 01/26/2012 | WO2011109326A3 Crosslinking reagents, methods, and compositions for studying protein-protein interactions |
| 01/26/2012 | WO2011084548A3 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 01/26/2012 | WO2011036267A3 Serum infrared spectroscopy for non invasive assessment of hepatic fibrosis in patients with chronic liver disease |
| 01/26/2012 | US20120023599 Genome editing of cytochrome p450 in animals |
| 01/26/2012 | US20120022793 Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population |
| 01/26/2012 | US20120022500 Compositions and Methods for Induced Brown Fat Differentiation |
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022166 Methods for Modulating Macrophage Proliferation Using Polyamine Analogs |
| 01/26/2012 | US20120022157 Dosing and monitoring patients on nitrogen-scavenging drugs |
| 01/26/2012 | US20120022131 Breast cancer related gene rqcd1 |
| 01/26/2012 | US20120022128 PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis |
| 01/26/2012 | US20120022006 B-lymphocyte stimulator binding polypeptides and methods based thereon |
| 01/26/2012 | US20120021998 Cancer Diagnosis and Treatment Methods of Use |
| 01/26/2012 | US20120021994 Novel cancer antigen eef2 |
| 01/26/2012 | US20120021968 Methods for treating or preventing urological inflammation |
| 01/26/2012 | US20120021946 Method of diagnosing esophageal cancer |
| 01/26/2012 | US20120021945 Hypoxia-Inducible Protein 2 (HIG2), a Diagnostic Marker for Clear Cell Renal Cell Carcinoma |
| 01/26/2012 | US20120021944 Co-Coupling To Control Reactivity Of Reagents In Immunoassays |
| 01/26/2012 | US20120021942 Use of fccs for the analysis of interaction parameters in an in vivo-like environment |
| 01/26/2012 | US20120021938 Method for detecting transcription factor-protein interactions |
| 01/26/2012 | US20120021937 Detection of carcinoma in situ in semen specimens |
| 01/26/2012 | US20120021935 Signature for the diagnosis of cancer aggressiveness and genetic instability |
| 01/26/2012 | US20120021934 Methods and Devices for Active Bioassay |
| 01/26/2012 | US20120021933 Small molecule printing |
| 01/26/2012 | US20120021929 Use of dppiv/seprase as a marker for cancer |
| 01/26/2012 | US20120021927 Methods for Determining a Prognosis for Survival for a Patient with Breast Cancer |
| 01/26/2012 | US20120021925 Diagnostic assays for prostate cancer using psp94 and psa biomarkers |
| 01/26/2012 | US20120021924 Detection and modulation of cytochrome c acetylation |
| 01/26/2012 | US20120021919 Identification of Differentially Represented Fetal or Maternal Genomic Regions and Uses Thereof |
| 01/26/2012 | US20120021534 Markers for brain damage |
| 01/26/2012 | US20120021532 Methods of Detecting and Treating Pulmonary Disease and Markers Thereof |
| 01/26/2012 | US20120021531 Assay Reader, Device and Method of Measuring HCG |
| 01/26/2012 | US20120021530 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS |
| 01/26/2012 | US20120021528 Method for Adding an Apparent Non-Signal Line to a Rapid Diagnostic Assay |
| 01/26/2012 | US20120021524 Microsensor for mercury |
| 01/26/2012 | US20120021456 Method and apparatus for detecting the presence of anisotropic crystals and hemozoin producing parasites in liquid blood |
| 01/26/2012 | US20120021444 Method for diagnosis of cystic fibrosis using kl-6 levels |
| 01/26/2012 | US20120021443 Directional surface plasmon coupled fluorescence and chemiluminescence from thin films of nickel, iron or palladium and uses thereof |
| 01/26/2012 | US20120021442 Markers for detection of complications resulting from in utero encounters |
| 01/26/2012 | US20120021441 In-process control in a method for producing epo |
| 01/26/2012 | US20120021439 Serial multiple antigen colocalization in paraffin-embedded tissue |
| 01/26/2012 | US20120021438 Method of Detecting Target, Method of Suppressing Increase in Background and Detection Apparatus |
| 01/26/2012 | US20120021437 Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 01/26/2012 | US20120021436 Crystal structure of human alpha-N-acetylglucosaminidase |
| 01/26/2012 | US20120021435 Detection of living, circulating, or disseminated cells or cell constituents in blood or bone marrow following filtration of blood |
| 01/26/2012 | US20120021434 Method for treating b cell regulated autoimmune disorders |
| 01/26/2012 | US20120021433 Reducing optical interference in a fluidic device |
| 01/26/2012 | US20120021432 Phosphorylated NF45 Biomarkers, Antibodies And Methods Of Using Same |
| 01/26/2012 | US20120021431 Diagnostic methods using bnp |
| 01/26/2012 | US20120021430 Functional lipid constructs |
| 01/26/2012 | US20120021426 Method of detecting target substance |
| 01/26/2012 | US20120021425 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 01/26/2012 | US20120021417 DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Nato3 |
| 01/26/2012 | US20120021414 Diagnostic markers of immunosenescence and methods of use thereof |
| 01/26/2012 | US20120021409 Common Light Chain Mouse |
| 01/26/2012 | US20120021407 Methods and Devices for Rapid Urine Concentration |
| 01/26/2012 | US20120021101 Method for sorting potato products and sorting apparatus for potato products |
| 01/26/2012 | US20120021064 Compositions for bowel preparation and methods of use thereof |
| 01/26/2012 | US20120021047 Id-1 Gene and Gene Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020983 Emp2 antibodies and their therapeutic uses |
| 01/26/2012 | US20120020978 Antibodies against fatty acid synthase |
| 01/26/2012 | US20120020974 Optimizing erythropoietin therapy |
| 01/26/2012 | US20120020972 Antibodies relating to pivka-ii and uses thereof |
| 01/26/2012 | US20120020970 Methods of evaluating patients |
| 01/26/2012 | US20120020966 Multispecific antibody targeting and multivalency through modular recognition domains |
| 01/26/2012 | US20120020961 Methods and compositions for liver cancer therapy |
| 01/26/2012 | US20120020959 Use of the sparc microenvironment signature in the treatment of cancer |
| 01/26/2012 | US20120020955 Detection of Neurological Disorders With Immune Reactions |
| 01/26/2012 | US20120020954 Methods of predicting clinical course and treating multiple sclerosis |
| 01/26/2012 | US20120020953 Diagnosis and treatment of cancer |
| 01/26/2012 | US20120020929 Methods and compositions relating to neuronal cell and tissue differentiation |
| 01/26/2012 | US20120020912 Prostate cancer vaccine |
| 01/26/2012 | US20120020889 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin |
| 01/26/2012 | US20120020888 Biomarker |
| 01/26/2012 | US20120020878 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
| 01/26/2012 | US20120020876 Hedgehog pathway inhibitors |
| 01/26/2012 | US20120020850 Crystallization system and method for promoting crystallization |
| 01/26/2012 | US20120020838 Automatic analysis device and dispensing device |
| 01/26/2012 | US20120020837 Portable Apparatus for Improved Sample Analysis |
| 01/26/2012 | US20120020831 Airflow controlling device and method |
| 01/26/2012 | US20120018302 Biosensor unit and biosensor system |
| 01/26/2012 | US20120018301 Nanoelectronic electrochemical test device |
| 01/26/2012 | US20120017705 Sensing Apparatus for Ground Sensing from the Interiior of a Vehicle, and Vehicle Having Such a Sensing Apparatus |
| 01/26/2012 | DE10228497B4 Verfahren und Vorrichtung zum Ermitteln eines Anteils eines für die Stoffwechselfunktion eines atmenden Lebewesens charakteristischen Bestandteils in der von dem Lebewesen ausgeatmeten Luft Method and apparatus for determining a share of a characteristic of the metabolic function of a living organism breathing component in the exhaled air of the creatures |
| 01/26/2012 | DE102010032718A1 Device for determining presence or amount of human chorionic gonadotropin in e.g. blood, has line element on housing at region of window-like opening, and cooperating with window-like opening for displaying positive presence of analytes |
| 01/26/2012 | DE102010032203A1 Verfahren und Vorrichtung zur passiven Trennung und Sortierung von Tropfen, insbesondere in einem mikrofluidischen System, durch Verwendung von nicht-optischen Markern für Reaktionen innerhalb der Tropfen Method and apparatus for passive separation and sorting of drops, particularly in a microfluidic system, by use of non-optical markers for reactions within the drop |
| 01/26/2012 | DE102010032123A1 Device for detecting volatile substance from e.g. person in e.g. public facility, has half cylinder to guide air flowed into suction unit to gas sensor used for detecting substance from person entered between fan and suction units |
| 01/26/2012 | DE102010032081A1 Nachweis lebender, zirkulierender oder disseminierter Zellen bzw. Zellbestandteile in Blut oder Knochenmark nach Filtration von Blut Detecting living, circulating or disseminated cells or cell components in blood or bone marrow after filtration of blood |
| 01/26/2012 | DE102010020622B4 Verfahren und Vorrichtung zur Bestimmung des Umhüllungsgrades von Bindemittel in bindemittelumhülltem gebrochenem, zum Bindemittel optisch unterschiedlich reflektierendem Festmaterial Method and apparatus for determining the coating level of binder in bindemittelumhülltem broken, the binder different optical reflective solid material |
| 01/26/2012 | DE102009013748B4 Bestimmung von Interaktionen konstanter Antikörperteile mit Fc-gamma Rezeptoren Determination of interactions constant antibody portions with Fc-gamma receptors |
| 01/26/2012 | DE102007056198B4 Beurteilung der Wirkung eines endogenen oder exogenen Einflusses auf Epithelgewebe durch Kartierung des Gewebes mittels markierter histologischer Gewebeschnitte Evaluation of the effect of an endogenous or exogenous influence on epithelial tissue by mapping the tissue by means of labeled histological tissue sections |
| 01/26/2012 | DE102007031574B4 Minor-Spleißosom Testsystem zur Modulierung der Zellteilung Minor spliceosome test system for modulating cell division |
| 01/26/2012 | DE102006033663B4 Verfahren zur Ermittlung eines charakteristischen Parameters einer Probe aus CFK Method for determining a characteristic parameter of a sample made of CFRP |
| 01/26/2012 | CA2842294A1 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 01/26/2012 | CA2811150A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | CA2809111A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |